Mawallafi: Clyde Lopez
Ranar Halitta: 18 Yuli 2021
Sabuntawa: 13 Yiwu 2024
Anonim
Top 10 Most HARMFUL Foods People Keep EATING
Video: Top 10 Most HARMFUL Foods People Keep EATING

Wadatacce

Salts na phosphate suna nufin haɗuwa da yawa na sunadarai phosphate tare da salts da ma'adanai. Abincin da ke dauke da sinadarin phosphate sun hada da kayayyakin kiwo, hatsi iri daya, kwayoyi, da wasu nama. Phosphates da aka samo a cikin kayan kiwo da nama suna da alama jiki yana saurin sauƙaƙawa fiye da phosphates da ake samu a cikin hatsin hatsi. Abincin Cola yana dauke da sinadarin phosphate da yawa - sosai, a zahiri, cewa zasu iya haifar da yawan phosphate a cikin jini.

Mutane suna amfani da gishirin fosfat don magani. Yi hankali kada ka rikitar da gishirin fosfat da abubuwa kamar su organophosphates, wadanda suke da guba sosai.

An fi amfani da gishirin fosfat don tsarkakewar hanji, da karancin jini na sinadarin phosphate, da maƙarƙashiya, da yawan ƙwayoyin calcium, da ƙwannafi.

Magunguna na Compwararren Bayanan Bayanai ƙimar tasiri bisa ga shaidar kimiyya bisa ga mizani mai zuwa: Inganci, Mai yuwuwa Mai Yiwuwa, Yiwuwar Tasiri, Yiwuwar Mara Inganci, Mai yiwuwa Mara Inganci, Mara Inganci, da suarancin Shaida don Rate.

Effectivenessimar tasiri don RUWAN SALATI sune kamar haka:


Inganci don ...

  • Shirya hanji don aikin likita. Shan kayan sodium phosphate a baki kafin aikin hanji na tasiri ga tsarkakewar hanji. Wasu samfuran sodium phosphate (OsmoPrep, Salix Pharmaceuticals; Visicol, Salix Pharmaceuticals) sun sami izinin Hukumar Abinci da Magunguna ta Amurka (FDA) don wannan nuni. Koyaya, shan sodium phosphate na iya kara barazanar lalata koda a wasu mutane. Saboda wannan, ana amfani da samfuran sodium phosphate a cikin Amurka don shirye-shiryen hanji.
  • Levelsananan matakan phosphate a cikin jini. Shan sinadarin sodium ko potassium phosphate da baki na da tasiri don hana ko magance ƙananan matakan phosphate a cikin jini. Hakanan salts na cikin jini na iya magance ƙananan matakan phosphate a cikin jini yayin amfani dasu ƙarƙashin kulawar likita.

Da alama tasiri ga ...

  • Maƙarƙashiya. Sodium phosphate wani sinadari ne mai izinin FDA (OTC) wanda aka ba da izinin kula da maƙarƙashiya. Ana ɗaukar waɗannan samfuran ta bakin ko amfani dasu azaman enemas.
  • Rashin narkewar abinci. Aluminum phosphate da calcium phosphate sune sinadaran da aka ba da izinin FDA da ake amfani da su a cikin maganin antacids.
  • Matakan alli a cikin jini. Shan gishirin fosfa (banda alli phosphate) ta bakin yana da tasiri sosai don magance yawan ƙwayoyin calcium a cikin jini. Amma bai kamata ayi amfani da gishirin cikin jini ba.

Yiwuwar tasiri ga ...

  • Koda duwatsu (nephrolithiasis). Shan potassium phosphate da baki na iya taimakawa hana dutsen kalshiyyan koda ya samu a marasa lafiya tare da yawan fitsari na alli.

Evidencearancin shaida don kimanta inganci don ...

  • Wasan motsa jiki. Wasu bincike na farko sun nuna cewa shan sodium phosphate ta baki tsawon kwanaki 6 kafin hawan keke mai karfi ko gudu zai iya inganta wasan motsa jiki. Amma sauran binciken farko basu nuna fa'ida ba. Ana buƙatar ƙarin karatu a cikin rukunin mutane da yawa don ganin sodium phosphate yana da fa'ida da gaske. Shan wasu salts na salts irin su calcium phosphate ko potassium phosphate baya inganta gudu ko motsa jiki.
  • Ciwon sukari (ciwon sukari ketoacidosis). Binciken farko ya nuna cewa bada potassium phosphate cikin jini (ta IV) ba ya inganta matsalar ciwon suga wanda jiki ke samar da sinadarin jini da yawa da ake kira ketones. Mutanen da suke da wannan yanayin ya kamata a basu phosphates ne kawai idan suna da ƙananan matakan phosphate.
  • Osteoporosis. Bincike ya nuna cewa shan sinadarin calcium a baki yana taimakawa wajen inganta kashin kashin hanji da kashin baya ga mata masu fama da cutar sanyin kashi. Amma ba ya aiki mafi kyau fiye da sauran tushen alli, irin su calcium carbonate.
  • Matsalolin da ke faruwa yayin cin abinci a cikin mutanen da yunwa ta taɓa addabarsu (sakewa ciwo). Binciken farko ya nuna cewa bada sinadarin sodium da potassium phosphate a cikin intraven (ta IV) sama da awanni 24 yana hana sake kamuwa da cutar yayin sake farawa abinci mai gina jiki ga mutanen da ke cikin matsanancin yunwa ko yunwa.
  • Hakora masu saurin ji.
  • Sauran yanayi.
Ana buƙatar ƙarin shaida don kimanta gishirin fosfat don waɗannan amfani.

Phosphates galibi ana ɗauke su daga abinci kuma suna da mahimmancin sunadarai a cikin jiki. Suna cikin tsarin kwayar halitta, jigilar makamashi da adanawa, aikin bitamin, da sauran matakai masu mahimmanci masu mahimmanci ga lafiya. Gishirin Phosphate na iya yin aiki azaman laxatives ta hanyar haifar da ƙarin ruwa zuwa cikin hanji da motsa hanji don fitar da abin da ke ciki da sauri.

Gishirin Phosphate dauke da sodium, potassium, aluminum, ko calcium sune LAFIYA LAFIYA ga yawancin mutane lokacin da aka ɗauke su da baki, aka saka a cikin dubura, ko kuma aka bayar da su ta hanji (ta hanyar IV) yadda ya dace da kuma gajeren lokaci. Ya kamata a yi amfani da gishirin Phosphate kawai ta hanyar jini (ta hanyar IV) a karkashin kulawar likita.

Gishirin Phosphate (wanda aka bayyana azaman phosphorous) sune YIWU KA KIYAYE lokacin da aka sha a cikin allurai sama da gram 4 a kowace rana don manya waɗanda shekarunsu ba su wuce shekaru 70 ba da gram 3 kowace rana ga mutanen da suka manyanta.

Amfani da dogon lokaci na yau da kullun na iya ɓata daidaituwar phosphates da sauran sunadarai a cikin jiki kuma ya kamata kwararrun masu kula da lafiya su kula da su don kauce wa mummunan sakamako. Gishirin Phosphate na iya harzuka hanyar narkewar abinci da haifar da tashin hankali, gudawa, maƙarƙashiya, ciwon kai, gajiya, da sauran matsaloli.

Kada ku dame gishirin phosphate da abubuwa kamar su organophosphates, ko kuma tare da tribasic sodium phosphates da tribasic potassium phosphates, wadanda suke da guba sosai.

Kariya & Gargaɗi na Musamman:

Ciki da shan nono: Magungunan Phosphate daga tushen abincin sune LAFIYA LAFIYA ga mata masu juna biyu ko masu shayarwa yayin amfani da su a cikin alawus ɗin da aka ba da shawarar na 1250 MG kowace rana ga iyaye mata tsakanin shekarun 14-18 zuwa 700 MG kowace rana ga waɗanda suka wuce shekaru 18. Sauran adadin sune YIWU KA KIYAYE kuma ya kamata a yi amfani dashi kawai tare da shawara da ci gaba da kulawa da ƙwararren masanin kiwon lafiya.

Yara: Gishirin Phosphate sune LAFIYA LAFIYA ga yara lokacin da aka yi amfani da su a cikin alawus ɗin yau da kullun na 460 MG na yara shekaru 1-3; 500 MG na yara 4-8 shekaru; da 1250 MG na yara shekaru 9-18. Gishirin Phosphate sune YIWU KA KIYAYE idan adadin phosphate da aka cinye (wanda aka bayyana azaman phosphorous) ya wuce matakin cin abinci na sama (UL). ULs sune gram 3 kowace rana ga yara shekaru 1-8; da gram 4 kowace rana ga yara shekaru 9 zuwa sama.

Ciwon zuciya: Ka guji amfani da gishirin fosfat wanda yake dauke da sinadarin sodium idan kana da cutar zuciya.

Ruwan ruwa (edema): Ka guji amfani da gishirin fosfat wanda ke dauke da sinadarin sodium idan kana da cutar cirrhosis, rashin karfin zuciya, ko kuma wasu yanayin da ka iya haifar da kumburi.

Babban matakan alli a cikin jini (hypercalcemia): Yi amfani da gishirin fosfat a hankali idan kana da cutar hypercalcemia. Yawan sinadarin phosphate na iya haifar da sanya alli a inda bai kamata a jikinka ba.

Babban matakan phosphate a cikin jini: Mutanen da ke da cutar Addison, cututtukan zuciya da huhu mai tsanani, cututtukan koda, matsalolin thyroid, ko cutar hanta sun fi sauran mutane saurin ɓarkewar ƙwayar phosphate da yawa a cikin jininsu lokacin da suke shan gishirin fosfat. Yi amfani da gishirin fosfat kawai tare da shawara da ci gaba da kulawa na ƙwararren likita idan kuna da ɗayan waɗannan sharuɗɗan.

Ciwon koda: Yi amfani da gishirin fosfat kawai tare da shawara da ci gaba da kulawa da kwararrun likitocin idan kana da matsalar koda.

Matsakaici
Yi hankali da wannan haɗin.
Bisphosphonates
Magungunan Bisphosphonate da salts na salts na iya rage matakan alli a jiki. Shan yawan salts na salts tare da magungunan bisphosphonate na iya haifar da matakan alli ya zama ƙasa da ƙasa.

Wasu bisphosphonates sun hada da alendronate (Fosamax), etidronate (Didronel), risedronate (Actonel), tiludronate (Skelid), da sauransu.
Alli
Phosphate zai iya haɗuwa tare da alli. Wannan yana rage karfin jiki na shan sinadarin phosphate da alli. Don kauce wa wannan hulɗar, ya kamata a sha phosphate aƙalla awanni 2 kafin ko bayan shan alli.
Arfe
Phosphate zai iya haɗuwa da baƙin ƙarfe. Wannan yana rage karfin jiki na shan sinadarin phosphate da iron. Don kaucewa wannan hulɗar, ya kamata a sha phosphate aƙalla awanni 2 kafin ko bayan shan ƙarfe.
Magnesium
Phosphate zai iya haɗuwa da magnesium. Wannan yana rage karfin jiki na shan sinadarin phosphate da magnesium. Don kauce wa wannan hulɗar, ya kamata a sha phosphate aƙalla awanni 2 kafin ko bayan shan magnesium.
Abinci mai dauke da sinadarin Phosphate da abin sha
A ka'ida, shan phosphate tare da abinci mai dauke da sinadarin phosphate na iya kara yawan sinadarin phosphate da kuma kara barazanar illa, musamman ga mutanen da ke da matsalar koda. Abincin da ke dauke da sinadarin Phosphate da abubuwan sha sun hada da cola, giya, giya, hatsin hatsi, kwayoyi, kayan kiwo da wasu nama.
An yi nazarin ƙwayoyi masu zuwa a cikin binciken kimiyya:

TA BAKI:
  • Don haɓaka matakan phosphate waɗanda suke da ƙarancin ƙarfi: Masu ba da lafiya suna auna matakan sinadarin phosphate da alli a cikin jini kuma suna ba da isasshen fosfes don gyara matsalar.
  • Don rage matakan alli waɗanda suke da yawa: Masu ba da lafiya suna auna matakan sinadarin phosphate da alli a cikin jini kuma suna ba da isasshen fosfes don gyara matsalar.
  • Don shirya hanji don aikin likita: Allunan kwaya uku zuwa hudu (OsmoPrep, Salix Pharmaceuticals; Visicol, Salix Pharmaceuticals) kowannensu dauke da gram 1.5 na sodium phosphate ana shansu da oza 8 na ruwa kowane minti 15 domin jimlar allunan 20 da yamma kafin a gama binciken kwayoyin cuta. Washegari, ana shan allunan 3-4 tare da oza 8 na ruwa kowane minti 15 har sai an sha allunan 12-20.
  • Koda duwatsu (nephrolithiasis): Anyi amfani da sinadarin potassium da sodium phosphate wadanda suke samar da 1200-1500 mg na elemental phosphate a kullum.
TA HU IVU:
  • Don haɓaka matakan phosphate waɗanda suke da ƙarancin ƙarfi: Anyi amfani da kayayyakin cikin jini (IV) dauke da sinadarin sodium phosphate ko potassium phosphate. An bada kashi 15-30 mmol akan awanni 2-12. An yi amfani da allurai mafi girma idan an buƙata.
Abubuwan da aka ba da izini na yau da kullun na abinci (RDAs) na phosphate (wanda aka bayyana azaman phosphorus) sune: Yara Childrenan shekaru 1-3, 460 mg; yara 4-8 shekaru, 500 MG; maza da mata shekaru 9-18, 1250 MG; maza da mata sama da shekaru 18, 700 MG.
Abubuwan da ake buƙata (AI) don jarirai sune: 100 MG ga jarirai 0-6 watanni da haihuwa da 275 MG don jarirai watanni 7-12.
Matakan Ciwo Na Sama (UL), matakin cin abinci mafi girma wanda ba a tsammanin sakamakon illa da ake so, don sinadarin phosphate (wanda aka bayyana azaman phosphorus) a kowace rana sune: yara daga shekaru 1-8, gram 3 kowace rana; yara da manya shekaru 9-70, gram 4; manya sun girmi shekaru 70, gram 3; mata masu ciki shekaru 14-50, gram 3.5; da mata masu shayarwa shekaru 14-50, gram 4. Aluminum phosphate, Bone Phosphate, Calcium phosphate, Calcium Orthophosphate, Calcium Phosphate Dibasic Anhydrous, Calcium Phosphate-Bone Ash, Calcium Phosphate Dibasic Dihydrate, Calcium Phosphate Dibasique Anhydre, Calcium Phosphate Dibasique Dihydrate, Calcium Phosphate Kotas, Calcium Phosphate , Di-Calcium Phosphate, Dicalcium Phosphate, Dical calcium Phosphates, Neutral Calcium Phosphate, Orthophosphate de Calcium, Phosphate d'Aluminium, Phosphate de Calcium, Phosphate de Magnésium, Phosphate Neutre de Calcium, Phosphate d'Os, Phosphate Tricalcium, Tsinkayen Précipitation du Phosphate de Calcium, Précipité de Phosphate de Calcium, Tertiary Calcium Phosphate, Tricalcium Phosphate, Whitlockite, Magnesium Phosphate, Merisier, Potassium phosphate, Dibasic Potassium Phosphate, Dipotium Hydrogen Orthophosphate, Dipotium Monophosphate, potassium , Potassium Biphosphate, Potassium Dihydrogen Orthophosphate, Potassium Hydrogen Phosphate, Phosphate de Dipotassium, Phosphate d'Hydrogène de Potassium, Phosphate de Potassium, Phosphate de Potassium Dibasique, Phosphate de Potassium Monobasique, Sodium phosphate, Anhydrous Sodium Phosphate, Dibasic Sodium Phosphate, , Disodium Hydrogen Orthophosphate Dodecahydrate, Disodium Hydrogen Phosphate, Disodium Phosphate, Phosphate na Soda, Sales de Fosfato, Sels de Phosphate, Sodium Orthophosphate, Orthophosphate Disodique d'Hydrogène, Phosphate Disodique d'Hydrogène, Dandalin de Sodium Dibasique, Phosphorus.

Don ƙarin koyo game da yadda aka rubuta wannan labarin, da fatan za a duba Magunguna na Compwararren Bayanan Bayanai hanya.


  1. Allunan Visicol Rubuta bayanai. Salix Pharmaceuticals, Raleigh, NC. Maris 2013. (https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021097s016lbl.pdf). An shiga 09/28/17.
  2. Delegge M, Kaplan R. Ingancin shirye-shiryen hanji tare da amfani da wanda aka shirya, ƙaramin abinci mai ƙarancin fiber tare da ƙaramin sodium, magnesium citrate cathartic vs. wani ruwa mai tsafta tare da ingantaccen sodium phosphate cathartic. Aliment Pharmacol Ther. 2005 Jun 15; 21: 1491-5. Duba m.
  3. Johnson DA, Barkun AN, Cohen LB, et al.; Kungiyar Multiungiyar Jama'a ta Jama'a ta Amurka kan Ciwon Cancer na Yankin Ciki. Inganta Ingantaccen Ingantaccen Wankewar Cikin hanji don Ganowa: Shawarwari Daga Multiungiyar -ungiyar USungiyoyin onungiyoyin Jama'a ta Amurka Kan Ciwon Cancer na Mallaka. Am J Gastroenterol na 2014; 109: 1528-45. Duba m.
  4. Nam SY, Choi IJ, Park KW, Ryu KH, Kim BC, Sohn DK, Nam BH, Kim CG. Hadarin cututtukan cututtukan ciki da ke tattare da maganin cikin hanji ta hanyar amfani da maganin sodium phosphate na baka. Osarshen hoto. 2010 Feb; 42: 109-13. Duba m.
  5. Ori Y, Rozen-Zvi B, Chagnac A, Herman M, Zingerman B, Atar E, Gafter U, Korzets A. Mutuwar mutane da kuma mummunan cututtukan rayuwa da ke haɗuwa da amfani da sodium phosphate enemas: ƙwarewar cibiyar guda ɗaya. Arch Intern Med. 2012 Feb 13; 172: 263-5. Duba m.
  6. Ladenhauf HN, Stundner O, Spreitzhofer F, Deluggi S. Tsananin hyperphosphatemia bayan gudanarwa na sodium-phosphate dauke da laxatives a cikin yara: jerin maganganu da nazari na yau da kullun na wallafe-wallafe. Pediatr Surg Int. 2012 Aug; 28: 805-14. Duba m.
  7. Schaefer M, Littrell E, Khan A, Patterson ME. Ididdigar GFR ta ƙi bin Sodium Phosphate Enemas da Polyethylene Glycol don Gano Gano: Nazarin Coungiyoyin Nazari. Am J Kidney Dis. 2016 Apr; 67: 609-16. Duba m.
  8. Brunelli SM. Associationungiyar tsakanin shirye-shiryen hanji na sodium phosphate da ciwon koda: nazari na yau da kullun da meta-bincike. Am J Kidney Dis. 2009 Mar; 53: 448-56. Duba m.
  9. Choi NK, Lee J, Chang Y, Kim YJ, Kim JY, Song HJ, Shin JY, Jung SY, Choi Y, Lee JH, Park BJ. Failureananan gazawar koda bayan bin sodium phosphate hanji shirye-shiryen: nazari na ƙasa-crossover. Osarshen hoto. 2014 Jun; 46: 465-70. Duba m.
  10. Belsey J, Crosta C, Epstein O, Fischbach W, Layer P, Parente F, Halphen M. Meta-bincike: tasirin dangi na shirye-shiryen hanji na baka don colonoscopy 1985-2010. Aliment Pharmacol Ther. 2012 Janairu; 35: 222-37. Duba m.
  11. Belsey J, Crosta C, Epstein O, Fischbach W, Layer P, Parente F, Halphen M. Meta-bincike: inganci na ƙananan hanji don ƙananan hancin bidiyo na endoscopy. Maganar Curr Med Resin. 2012 Dec; 28: 1883-90. Duba m.
  12. Czuba M, Zajac A, Poprzecki S, Cholewa J, Woska S. Hanyoyin Sodium Phosphate Loading a kan Aerobic Power da Capacity a cikin kashe Road Cyclists. J Wasanni Sci Med. 2009 Dec 1; 8: 591-9. Duba m.
  13. Brewer CP, Dawson B, Wallman KE, Guelfi KJ. Sakamakon tasirin sodium phosphate da aka maimaita akan aikin gwajin lokacin motsa jiki da VO2peak. Int J Sport Nutr Motsa jiki Metab. 2013 Apr; 23: 187-94. Duba m.
  14. Buck CL, Wallman KE, Dawson B, Guelfi KJ. Sodium phosphate azaman taimakon ergogenic. Wasanni Med. 2013 Jun; 43: 425-35. Duba m.
  15. Buck CL, Dawson B, Guelfi KJ, McNaughton L, Wallman KE. Diumarin sodium phosphate da gwajin gwaji na lokaci a cikin mata masu keken mata. J Wasanni Sci Med. 2014 Satumba 1; 13: 469-75. Duba m.
  16. Brewer CP, Dawson B, Wallman KE, Guelfi KJ. Tasirin diumarin Sodium Phosphate akan Peraddamar da Lokacin Gwajin Lokaci da VO2 1 da 8 Days Post Loading. J Wasanni Sci Med. 2014 Satumba 1; 13: 529-34. Duba m.
  17. West JS, Ayton T, Wallman KE, Guelfi KJ. Tasirin kwanakin 6 na karin sodium phosphate akan ci abinci, cin kuzari, da damar haɓaka a cikin horarwa maza da mata. Int J Sport Nutr Motsa jiki Metab. 2012 Dec; 22: 422-9. Duba m.
  18. van Vugt van Pinxteren MW, van Kouwen MC, van Oijen MG, van Achterberg T, Nagengast FM. Nazarin bincike na hanji don colonoscopy tare da polyethylene glycol-electrolyte bayani akan sodium phosphate a cutar Lynch: gwajin bazuwar. Cutar Cancer. 2012 Satumba; 11: 337-41. Duba m.
  19. Lee SH, Lee DJ, Kim KM, Seo SW, Kang JK, Lee EH, Lee DR. Kwatanta inganci da amincin allunan sodium phosphate da maganin polyethylene glycol don tsarkakewar hanji a cikin manya manya 'yan Koriya. Yonsei Med J. 2014 Nuwamba; 55: 1542-55. Duba m.
  20. Kopec BJ, Dawson BT, Buck C, Wallman KE. Hanyoyin sodium phosphate da maganin kafeyin akan tasirin sake-sakewa a cikin 'yan wasa maza. J Sci Med Wasanni. 2016 Mar; 19: 272-6. Duba m.
  21. Jung YS, Lee CK, Kim HJ, Eun CS, Han DS, Park DI. Gwajin gwajin da bazuwar sodium phosphate Allunan vs maganin polyethylene glycol don tsabtace hanji. Duniya J Gastroenterol. 2014 Nuwamba 14; 20: 15845-51. Duba m.
  22. Heaney RP, Recker RR, Watson P, Lappe JM. Phosphate da gishirin carbonate na alli suna tallafawa ƙashi mai ƙarfi a cikin osteoporosis. Am J Clin Nutr. 2010 Jul; 92: 101-5. Duba m.
  23. Ell C, Fischbach W, Layer P, Halphen M. Randomized, gwajin sarrafawa na 2 L polyethylene glycol tare da abubuwan ascorbate tare da sodium phosphate don tsabtace hanji kafin colonoscopy don binciken kansar. Maganar Curr Med Resin. 2014 Dec; 30: 2493-503. Duba m.
  24. Buck CL, Henry T, Guelfi K, Dawson B, McNaughton LR, Wallman K. Hanyoyin sodium phosphate da karin ruwan 'ya'yan itace a kan karfin maimaita saurin cikin mata. Eur J Appl Physiol. 2015 Oktoba; 115: 2205-13. Duba m.
  25. Buck C, Guelfi K, Dawson B, McNaughton L, Wallman K. Hanyoyin sodium phosphate da cafeine da ke ɗorawa a kan maimaita sakewa. J Wasanni Sci. 2015; 33: 1971-9. Duba m.
  26. Brewer CP, Dawson B, Wallman KE, Guelfi KJ. Tasirin ƙarin sodium phosphate akan yunƙurin hawan keke mai tsananin ƙarfi. J Wasanni Sci. 2015; 33: 1109-16. Duba m.
  27. Folland, JP, Stern, R, da Brickley, G. Sodium phosphate loading yana inganta dakin gwaje-gwaje na motsa jiki na motsa jiki lokacin gwaji a cikin masu koyar da keke. J Sci Med Wasanni 2008; 11: 464-8. Duba m.
  28. Fisher, JN da Kitabchi, AE. Nazarin bazuwa game da maganin fosfat a cikin maganin ketoacidosis na ciwon sukari. J Jarin Endocrinol Metab 1983; 57: 177-80. Duba m.
  29. Terlevich A, Ji SD, Woltersdorf WW, et al. Raunin ciwo: ingantaccen magani mai lafiya tare da Phosphates Polyfusor. Aliment Pharmacol Ther 2003; 17: 1325-9. Duba m.
  30. Savica, V, Calo, LA, Monardo, P, et al.Salivary phosphorus da phosphate abun ciki na abubuwan sha: abubuwan da suka shafi maganin uremic hyperphosphatemia. J Ren Nutr 2009; 19: 69-72. Duba m.
  31. Hu, S, Shearer, GC, Steffes, MW, Harris, WS, da Bostom, AG. Niacin sau ɗaya-a kowace rana yana fadada yawan sinadarin phosphorus a cikin marasa lafiya da cututtukan zuciya na dyslipidemia. Am J Kidney Dis 2011; 57: 181-2. Duba m.
  32. Schaiff, RA, Hall, TG, da Bar, RS. Kula da lafiya na hypercalcemia. Cibiyar Clin 1989; 8: 108-21. Duba m.
  33. Elliott, GT da McKenzie, MW. Jiyya na hypercalcemia. Magungunan Intell Clin Pharm 1983; 17: 12-22. Duba m.
  34. Bugg, NC da Jones, JA. Hypophosphataemia. Pathophysiology, tasiri da gudanarwa akan sashin kulawa mai mahimmanci. Magunguna 1998; 53: 895-902. Duba m.
  35. OsmoPrep Shirya bayani. Salix Pharmaceuticals, Raleigh, NC. Oktoba 2012. (http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021892s006lbl.pdf, isa ga 02/24/15).
  36. Jerin kayan abinci na FDA OTC, Afrilu 2010. Akwai a: www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/UCM135691.pdf (an isa ga 2/7/15).
  37. Finkelstein JS, Klibanski A, Arnold AL, et al. Rigakafin cututtukan cututtukan cututtukan estrogen tare da kwayar cutar parathyroid ta mutum- (1-34): gwajin gwajin bazuwar. JAMA 1998; 280: 1067-73. Duba m.
  38. Winer KK, Ko CW, Reynolds JC, et al. Dogon jiyya na hypoparathyroidism: Nazarin sarrafawa mai bazuwar kwatanta parathyroid hormone (1-34) akan calcitriol da alli. J Jarin Endocrinol Metab 2003; 88: 4214-20. Duba m.
  39. Lindsay R, Nieves J, Formica C, et al. Nazarin sarrafawa wanda bazuzu akan tasirin kwayar parathyroid akan kashin kashin baya da kasada da kuma raunin da ya faru tsakanin mata masu haihuwa bayan haihuwa akan estrogen tare da osteoporosis. Lancet 1997; 350: 550-5. Duba m.
  40. Winer KK, Yanovski JA, Cutler GB Jr. Cutar ɗan adam parathyroid hormone 1-34 vs calcitriol da calcium a cikin maganin hypoparathyroidism. JAMA 1996; 276: 631-6. Duba m.
  41. Leung AC, Henderson IS, Halls DJ, Dobbie JW. Aluminium hydroxide a kan sucralfate a matsayin mai ɗaukar sinadarin phosphate a cikin uraemia. Br Med J (Clin Res Ed) 1983; 286: 1379-81. Duba m.
  42. Roxe DM, Mistovich M, Barch DH. Hanyoyin da ke tattare da fosfat na nasara a cikin marasa lafiya tare da raunin koda. Am J Kidney Dis 1989; 13: 194-9. Duba m.
  43. Hergesell O, Ritz E. Phosphate suna ɗaure kan ƙarfe: sabon hangen nesa? Abubuwan Cikin Kidney na 1999; 73: S42-5. Duba m.
  44. Peters T, Apt L, Ross JF. Tasirin phosphates akan shan ƙarfe da aka karanta a cikin batutuwa na yau da kullun na mutane kuma a cikin ƙirar gwaji ta amfani da dialysis. Gastroenterology 1971; 61: 315-22. Duba m.
  45. Monsen ER, Cook JD. Shan ƙarfen abinci a cikin batutuwa na mutane IV. Illar alli da salts na salts a kan shawar baƙin ƙarfe mara zafi. Am J Clin Nutr 1976; 29: 1142-8. Duba m.
  46. Lindsay R, Nieves J, Henneman E, et al. Cutaddamar da ƙananan ƙananan amino-m yanki na mutum parathyroid hormone- (1-34): motsi da kuma maganin biochemical a cikin estrogenized osteoporotic marasa lafiya. J Jarin Endocrinol Metab 1993; 77: 1535-9. Duba m.
  47. Campisi P, Badhwar V, Morin S, Trudel JL. Tetany na hypocalcemic na tiyata bayan Fleet Phospho-Soda shiri a cikin mai haƙuri shan alendronate sodium. Coungiyar Maɗaukaki ta 1999; 42: 1499-501. Duba m.
  48. Loghman-Adham M. Tsaro na sabbin dunƙulen phosphate don ciwan koda na kullum. Drug Saf 2003; 26: 1093-115. Duba m.
  49. Schiller LR, Santa Ana CA, Sheikh MS, et al. Amfanin lokacin gudanar da alli acetate akan phosphorus dauri. Sabon Engl J Med 1989; 320: 1110-3. Duba m.
  50. Saadeh G, Bauer T, Licata A, Sheeler L. Antacid-haifar da osteomalacia. Cleve Clin J Med 1987; 54: 214-6. Duba m.
  51. Gregory JF. Nazarin nazari: samar da kwayar halitta. J Nutr 2001; 131: 1376S-1382S. Duba m.
  52. Insogna KL, Bordley DR, Caro JF, Lockwood DH. Osteomalacia da rauni daga yawan shan antacid. JAMA 1980; 244: 2544-6. Duba m.
  53. Heaney RP, Nordin BE. Hanyoyin calcium akan shayarwar phosphorus: abubuwan da suka shafi rigakafi da haɗin gwiwa na osteoporosis. J Am Coll Nutr 2002; 21: 239-44 .. Duba m.
  54. Rosen GH, Boullata JI, O'Rangers EA, et al. Tsarin cikewar phosphate mai cike da jini don marasa lafiya masu tsananin rashin lafiya tare da matsakaiciyar hypophosphatemia. Kulawa na Kula da Lafiya 1995; 23: 1204-10. Duba m.
  55. Perreault MM, Ostrop NJ, Tierney MG. Inganci da amincin maye gurbin phosphate cikin marasa lafiya marasa lafiya. Ann Pharmacother 1997; 31: 683-8. Duba m.
  56. Duffy DJ, Conlee RK. Hanyoyin tasirin fosfat akan karfin kafa da motsa jiki mai tsananin karfi. Jirgin Wasannin Wasanni na Sci 1986; 18: 674-7. Duba m.
  57. Hukumar Abinci da Abinci, Cibiyar Magunguna. Abincin Abincin Abinci don Abinci, Phosphorus, Magnesium, Vitamin D, da Fluoride. Washington, DC: National Academy Press, 1999. Akwai a: http://books.nap.edu/books/0309063507/html/index.html.
  58. Carey CF, Lee HH, Woeltje KF (eds). Littafin Washington na Magungunan Magunguna. 29th ed. New York, NY: Lippincott-Raven, 1998.
  59. Alvarez-Arroyo MV, Traba ML, Rapado TA, et al. Daidaitawa tsakanin 1.25 dihydroxyvitamin D matakan magani da kuma kason kashi na shayar da alli a cikin hypercalciuric nephrolithiasis. Matsayin fosfat. Sakamakon Urol 1992; 20: 96-7. Duba m.
  60. Heaton KW, Lever JV, Barnard RE. Osteomalacia hade da maganin cholestyramine don cututtukan bayan gida. Gastroenterology 1972; 62: 642-6. Duba m.
  61. Becker GL. Shari'ar mai ma'adinai. Am J narkewa Dis 1952; 19: 344-8. Duba m.
  62. Schwarz KB, Goldstein PD, Witztum JL, et al. Vitaminwayar bitamin mai narkewa a cikin yara hypercholestrolemic waɗanda aka kula da su tare da colestipol. Ilimin yara na yara 1980; 65: 243-50. Duba m.
  63. Yammacin RJ, Lloyd JK. Tasirin cholestyramine akan shafan hanji. Gut 1975; 16: 93-8. Duba m.
  64. Spencer H, Menaham L. Mummunan sakamako na antacids mai dauke da aluminum akan tasirin ma'adinai. Gastroenterology 1979; 76: 603-6. Duba m.
  65. Roberts DH, Knox FG. Renal phosphate handling da calcium nephrolithiasis: rawar abincin abincin da ake amfani da shi da kuma yaduwar phosphate. Semin Nephrol 1990; 10: 24-30. Duba m.
  66. Harmelin DL, Martin FR, Wark JD. Ciwon ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta wanda ke gabatarwa azaman nephrolithiasis. Aust NZ J Med 1990; 20: 803-5. Duba m.
  67. Yates AA, Schlicker SA, Mai dacewa CW. Bayanin abinci ya shiga: Sabon tushe don shawarwari don alli da abubuwan gina jiki masu alaƙa, bitamin B, da choline. J Am Abincin Assoc 1998; 98: 699-706. Duba m.
  68. Fauci AS, Braunwald E, Isselbacher KJ, et al. Ka'idodin Harrison na Magungunan Cikin Gida, 14th ed. New York, NY: McGraw-Hill, 1998.
  69. Shils NI, Olson JA, Shike M, Ross AC, eds. Nutrition na Zamani cikin Kiwan Lafiya da Cuta. 9th ed. Baltimore, MD: Williams & Wilkins, 1999.
  70. Galloway SD, Tremblay MS, Sexsmith JR, Roberts CJ. Abubuwan da ke tattare da ƙarin haɓakar phosphate a cikin batutuwa daban-daban na matakan motsa jiki. Eur J Appl Physiol Ma'aikatar Physiol 1996; 72: 224-30. Duba m.
  71. Helikson MA, Parham WA, Tobias JD. Hypocalcemia da hyperphosphatemia bayan amfani da phosphate enema a cikin yaro. J Pediatr Surg 1997; 32: 1244-6. Duba m.
  72. Diunesma JA, Buckley SE, Warner BA, et al. Ilmin Biochemical na sodium phosphate na baka. Dig Dis Sci 1996; 41: 749-53. Duba m.
  73. Fine A, Patterson J. Tsarin hyperphosphatemia mai tsananin bin gwamnatin phosphate don shirye-shiryen hanji a cikin marasa lafiya tare da gazawar koda: sharuɗɗa biyu da sake nazarin wallafe-wallafe. Am J Kidney Dis 1997; 29: 103-5. Duba m.
  74. Clarkston WK, Tsen TN, Ya mutu DF, et al. Oral sodium phosphate tare da sulfate-free polyethylene glycol electrolyte lavage bayani a cikin asibitin marasa lafiya don colonoscopy: kwatancen da zai yiwu. Gastrointest Endosc 1996; 43: 42-8. Duba m.
  75. Hill AG, Teo W, Har yanzu A, et al. Ragewar sinadarin potassium yana sanya hypokalaemia bayan bakin sodium phosphate. Aust N Z J Surg 1998; 68: 856-8. Duba m.
  76. Heller HJ, Reza-Albarran AA, Breslau NA, Pak CY. Rage dorewa a cikin allurar urinary yayin magani na dogon lokaci tare da jinkirin sakin matsakaicin potassium phosphate a cikin hypercalciuria mai sha. J Urol 1998; 159: 1451-5; tattaunawa 1455-6. Duba m.
  77. Hardman JG, Limbird LL, Molinoff PB, eds. Goodman da Gillman's Tsarin Magungunan Magungunan Magunguna, 9th ed. New York, NY: McGraw-Hill, 1996.
  78. Saurayi DS. Hanyoyin Magunguna akan Gwajin Laboratory Clinical 4th ed. Washington: AACC Latsa, 1995.
  79. McEvoy GK, ed. AHFS Bayanin Magunguna. Bethesda, MD: Americanungiyar lafiyar Amurka-Tsarin Magunguna, 1998.
  80. Monographs kan amfani da magani na magungunan ƙwayoyi. Exeter, Burtaniya: Co-op Phytother na Kimiyyar Kimiyyar Turai, 1997.
Reviewedarshen sake dubawa - 01/29/2019

Duba

Ciwon ciki
Magani

Ciwon ciki

ilico i cuta ce ta huhu da ke haifar da numfa hi ( haƙar) ƙurar ilica. ilica abu ne na yau da kullun, wanda ke faruwa a dabi'ance. Ana amunta a mafi yawancin gadajen dut e. iffofin ƙirar ilica ya...
Opioid Rashin Amfani da Jaraba
Magani

Opioid Rashin Amfani da Jaraba

Opioid , wani lokacin ana kiran a narkoki, nau'ikan magani ne. un hada da ma u aurin magance radadin ciwo, kamar u oxycodone, hydrocodone, fentanyl, da tramadol. Har ila yau, heroin miyagun ƙwayoy...